RS67211B1 - Losion koji sadrži tazaroten za topikalnu upotrebu u lečenju akni - Google Patents

Losion koji sadrži tazaroten za topikalnu upotrebu u lečenju akni

Info

Publication number
RS67211B1
RS67211B1 RS20250918A RSP20250918A RS67211B1 RS 67211 B1 RS67211 B1 RS 67211B1 RS 20250918 A RS20250918 A RS 20250918A RS P20250918 A RSP20250918 A RS P20250918A RS 67211 B1 RS67211 B1 RS 67211B1
Authority
RS
Serbia
Prior art keywords
pharmaceutical composition
topical pharmaceutical
tazarotene
use according
composition
Prior art date
Application number
RS20250918A
Other languages
English (en)
Serbian (sr)
Inventor
Arturo Angel
Radhakrishnan Pillai
Original Assignee
Bausch Health Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch Health Ireland Ltd filed Critical Bausch Health Ireland Ltd
Publication of RS67211B1 publication Critical patent/RS67211B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
RS20250918A 2017-05-12 2018-05-11 Losion koji sadrži tazaroten za topikalnu upotrebu u lečenju akni RS67211B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762505421P 2017-05-12 2017-05-12
PCT/US2018/032359 WO2018209262A1 (en) 2017-05-12 2018-05-11 Topical compositions and methods for treating skin diseases
EP18727965.8A EP3621614B1 (en) 2017-05-12 2018-05-11 Lotion comprising tazarotene for topical use in the treatment of acne

Publications (1)

Publication Number Publication Date
RS67211B1 true RS67211B1 (sr) 2025-10-31

Family

ID=62386996

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20250918A RS67211B1 (sr) 2017-05-12 2018-05-11 Losion koji sadrži tazaroten za topikalnu upotrebu u lečenju akni

Country Status (8)

Country Link
US (1) US20180360752A1 (enExample)
EP (1) EP3621614B1 (enExample)
JP (1) JP7410720B2 (enExample)
BR (1) BR112019023817A8 (enExample)
CA (1) CA3063371A1 (enExample)
PL (1) PL3621614T3 (enExample)
RS (1) RS67211B1 (enExample)
WO (1) WO2018209262A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108282998B (zh) 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
CA3267519A1 (en) * 2022-09-16 2024-03-21 Bausch Health Ireland Ltd METHODS FOR TREATING ACNE AND OILY SKIN WITH TAZAROTENE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210041C (zh) * 2003-09-29 2005-07-13 中国医学科学院皮肤病研究所 治疗痤疮的复方外用药物
CN108282998B (zh) * 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物

Also Published As

Publication number Publication date
PL3621614T3 (pl) 2025-10-13
JP7410720B2 (ja) 2024-01-10
BR112019023817A8 (pt) 2022-12-06
JP2020519656A (ja) 2020-07-02
BR112019023817A2 (pt) 2020-06-02
CA3063371A1 (en) 2018-11-15
EP3621614A1 (en) 2020-03-18
US20180360752A1 (en) 2018-12-20
WO2018209262A1 (en) 2018-11-15
EP3621614B1 (en) 2025-06-25

Similar Documents

Publication Publication Date Title
US11648256B2 (en) Topical compositions and methods for treating psoriasis
CA3076002A1 (en) Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents
US20250017854A1 (en) Topical compositions and methods for treating skin diseases
US11839656B2 (en) Pharmaceutical formulations containing corticosteroids for topical administration
RS67211B1 (sr) Losion koji sadrži tazaroten za topikalnu upotrebu u lečenju akni
US20080175810A1 (en) Topical compositions for cosmetic and pharmaceutical use
US20190133943A1 (en) Topical compositions and methods for treating skin diseases
EA043055B1 (ru) Фармацевтические композиции рофлумиласта в водных смесях смешивающихся с водой фармацевтически приемлемых растворителей